Full-Time

AI Platform Lead

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior, Expert

Hyderabad, Telangana, India

Category
Applied Machine Learning
Natural Language Processing (NLP)
AI & Machine Learning
Required Skills
Python
JavaScript
NoSQL
SQL
AWS
Requirements
  • Master’s degree computer science and engineering (preferred) with 6+ years of software development experience OR
  • Bachelor’s degree in computer science and engineering (preferred) with 8+ years of software development experience
  • Hands on experience with various cloud services, understand pros and cons of various cloud service in well architected cloud design principles
  • Hands on experience with Full Stack software development. Proficient in programming language Python(preferred), JavaScript, SQL/NoSQL.
  • Proven ability to lead and mentor software development teams
  • Strong problem solving, analytical skills; Ability to learn quickly; Excellent communication and interpersonal skills
Responsibilities
  • Possesses strong rapid prototyping skills and can quickly translate concepts into working code
  • Provide technical guidance and management to the development team.
  • Take ownership of complex software projects from conception to deployment. Handle software delivery scope, risk, and timeline
  • Contribute to both front-end and back-end development using cloud technology.
  • Develop innovative solution using generative AI technologies
  • Define and implement robust software architectures on the cloud, AWS preferred
  • Lead and motivate a team of engineers to deliver high-quality results.
  • Conduct code reviews to ensure code quality and adherence to best practices.
  • Create and maintain documentation on software architecture, design, deployment, disaster recovery, and operations.
  • Identify and resolve technical challenges effectively.
  • Stay updated with the latest trends and advancements
  • Work closely with product team, business team, and other key partners.
Desired Qualifications
  • Experienced with API integration, serverless, microservices architecture.
  • Experience in SQL/NOSQL database, vector database for large language models
  • Experience with popular large language models
  • Experience with Langchain or llamaIndex framework for language models
  • Experience with prompt engineering, model fine tuning
  • Experience with Web site development, understand of web site localization processes, which involves adapting content to fit cultural and linguistic contexts.
  • Experience with DevOps/MLOps CICD build and deployment pipeline
  • Experience with design patterns, data structures, test-driven development.
  • Knowledge of NLP techniques for text analysis and sentiment analysis
  • Cloud Computing certificate preferred

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are medicines made from living organisms. These therapies target conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen stands out from competitors by reinvesting a large portion of its earnings into research and development, ensuring a strong pipeline of new treatments. The goal of Amgen is to improve patient care and outcomes through the discovery of effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.